The Valley Desk

ArticleEmerging microbes & infectionsPublished

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials

13 of 39 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Emerging microbes & infections
Published
Subject terms
CD4-Positive T-Lymphocytes; Humans; HIV-1; HIV Infections; Immunoglobulin G; Vaccines, DNA; AIDS Vaccines; HIV Antibodies; Immunization, Secondary; Adolescent; Adult; Middle Aged
PubMed ID
40190112
PubMed Central ID
PMC11980190
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal